Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sertoli cell transfer restores sperm production in infertile mice

18.11.2002


Scientists at the University of Pennsylvania School of Veterinary Medicine have successfully transplanted specialized cells that are critical to sperm development in mice, restoring sperm production in once-infertile animals.

The research, reported on the Web site of the journal Biology of Reproduction, may give scientists a better understanding of how Sertoli cells -- which surround spermatogenic stem cells -- nourish sperm production and the survival of stem cells.

"Spermatogenesis is a highly organized process, requiring just the right environment, or ’niche,’ around the germ line stem cells," said Ralph L. Brinster, professor of reproductive physiology at Penn. "The Sertoli cells are essential to this environment, and it appears that by replacing them, we can essentially reconstruct the niche in which sperm development takes place."



Much of the volume of a mammalian testis consists of tightly coiled seminiferous tubules that hold mature sperm. Sperm development also occurs within these tubules, which are home to spermatogenic stem cells, the seeds from which spermatogenesis arises. Seminiferous tubules are lined with Sertoli cells, which are thought to nurture sperm cells as they develop and facilitate their eventual passage out of the testis.

Brinster and colleagues worked with Steel mutant mice, which are congenitally infertile due to a Sertoli cell defect. Before inserting healthy Sertoli cells, the researchers treated the mice’s testes with busulfan and cadmium to remove any defective germ cells and Sertoli cells. The seminiferous tubules remained, likely providing the structural support needed to completely reconstitute spermatogenesis from donor cells.

The Brinster group’s technique for transplanting Sertoli cells will likely allow scientists to study stem cells’ specialized environment in a way that has not been possible before. Currently, the best-studied stem cells are those that generate blood cells, even though these cells, which reside in bone marrow, are relatively inaccessible to researchers.

"I believe Dr. Brinster’s new results have catapulted the spermatogenic stem cell system into a position of maximum experimental flexibility among all other stem cell systems in the body," said John R. McCarrey, professor of cell and molecular biology at the University of Texas at San Antonio, who was not involved in this work. "This may lead to significant new insight into the manner in which the spermatogenic stem cell works in particular as well as to additional information about how all stem cells work in general."

Brinster’s work could eventually prove useful in the treatment of certain types of infertility in men, although complete spermatogenesis was established in only 1.5 to 3 percent of seminiferous tubules in this experiment.

"Male infertility can be caused either by defective germ cells or by a testicular environment that fails to promote proper spermatogenesis," Brinster said. "While several assisted reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection, are now available for patients with low sperm counts, infertile patients with Sertoli cell defects have limited options."

The technique developed by Brinster and his colleagues may provide a new way of replacing defective Sertoli cells with healthy ones, which may initiate normal spermatogenesis in some infertile patients.


Brinster was joined in the research by Takashi Shinohara, now at Kyoto University, and Kyle E. Orwig and Mary R. Avarbock in Penn’s School of Veterinary Medicine. The work was funded by the Japan Society for Promotion of Science, the National Institute of Child Health and Human Development, the Commonwealth and General Assembly of Pennsylvania and the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation.


Steve Bradt | EurekAlert!
Further information:
http://www.upenn.edu/

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>